Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798998
Max Phase: Preclinical
Molecular Formula: C56H83ClN6O14
Molecular Weight: 1099.76
Molecule Type: Unknown
Associated Items:
ID: ALA4798998
Max Phase: Preclinical
Molecular Formula: C56H83ClN6O14
Molecular Weight: 1099.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](OC(=O)Cc2ccccn2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC(=O)CCNCCCNc2cc3c(=O)c(C(=O)O)cn(C4CC4)c3cc2Cl)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
Standard InChI: InChI=1S/C56H83ClN6O14/c1-12-44-56(8,72)50(68)35(6)62(11)29-31(2)28-55(7,77-45(64)19-23-58-20-15-22-60-41-26-38-42(27-40(41)57)63(37-17-18-37)30-39(47(38)66)52(69)70)51(76-54-48(67)43(61(9)10)24-32(3)73-54)33(4)49(34(5)53(71)74-44)75-46(65)25-36-16-13-14-21-59-36/h13-14,16,21,26-27,30-35,37,43-44,48-51,54,58,60,67-68,72H,12,15,17-20,22-25,28-29H2,1-11H3,(H,69,70)/t31-,32-,33+,34-,35-,43+,44-,48-,49+,50-,51-,54+,55-,56-/m1/s1
Standard InChI Key: BLIZWHHBCHRGQU-RPHKQJLFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1099.76 | Molecular Weight (Monoisotopic): 1098.5656 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fan BZ,Hiasa H,Lv W,Brody S,Yang ZY,Aldrich C,Cushman M,Liang JH. (2020) Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides., 193 [PMID:32200200] [10.1016/j.ejmech.2020.112222] |
Source(1):